SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosebank Regulatory News (ROSE)

Share Price Information for Rosebank (ROSE)

Share Price is delayed by 15 minutes
Get Live Data
350.00    12.00 (3.55%)
Bid:
350.00
Ask:
352.00
Spread: 2.00 (0.571%)
Market Cap: £3.46b
ROSE Live PriceLast checked at - London Stock Exchange

Intraday Rosebank Share Chart

Convertible Loan Notes

23 May 2012 07:00

RNS Number : 8980D
Vane Minerals PLC
23 May 2012
 



VANE Minerals plc (AIM:VML)

("VANE" or the "Company")

Convertible Loan Notes

VANE is pleased to announce that the Company has reached an agreement with the holders of its convertible loan notes.

VANE currently has two convertible loan notes outstanding, the first for £1m, issued to Geiger Counter Limited in May 2007 which was due to be repaid at end of May 2012; and the second loan, amounting to £500,000, was issued to City Natural Resources High Yield Trust plc in September 2007 and was due to be repaid at end of September 2012. Both funds are managed by New City Investment Managers.

The principal points of the agreement are:

·; VANE will repay £500,000 on 31 May 2012 out of existing cash resources to settle the loan with City Natural Resources High Yield Trust plc

·; VANE will carry forward a loan note of £1 million, issued to Geiger Counter Limited (the "new loan note")

·; The maturity date for the new loan note is 31 May 2017

·; The new loan note will continue to attract interest at 8% per annum, payable every six months

·; The new loan note is convertible by the holder, at any time, into 80 million ordinary shares in VANE at a price of 1.25p (a 34 per cent premium to the current mid-market price of 0.935p per ordinary share as at the close of business on 22 May 2012)

·; The Company may repay the loan note early in the event that i) the share price is equal or greater than 2.5p or ii) after three years, the share price is equal or greater than 1.25p. The amount which the Company would have to pay in these circumstances is calculated by multiplying the prevailing share price by the number of shares into which the loan note is convertible at 1.25p per Ordinary Share

·; VANE has undertaken to seek shareholder approval to dis-apply the relevant pre-emption rights at a general meeting, thus enabling conversion of the new loan note

David Newton, Chief Executive of VANE, commented:

"I am delighted to have reached this agreement with the loan note holders. The maximum dilution to existing shareholders would equate to only 15.3% of the enlarged share capital of the Company and the agreement allows the Company to continue to devote its current cash resources to the development of its highly promising copper and uranium exploration assets."

 

For further information, please contact:

VANE Minerals Plc

+44 (0) 20 7667 6322

David Newton

CEO VANE Minerals plc

 

 

Allenby Capital (Nominated Adviser & Joint Broker)

Jeremy Porter/Alex Price

 

Northland Capital Markets (Joint Broker)

Louis Castro

 

 

+44 (0) 203328 5656

 

 

+44 (0) 20 7796 8821

 

Bankside Consultants

 

+44 (0) 20 7367 8888

Simon Rothschild

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAASAAFNAEAF
Date   Source Headline
31st Dec 20191:00 pmRNSTotal Voting Rights
3rd Dec 201912:27 pmRNSIssue of Equity and change to TVR
29th Nov 20195:00 pmRNSTotal Voting Rights
22nd Nov 20194:52 pmRNSHolding(s) in Company
21st Nov 201912:43 pmRNSResult of General Meeting and change to TVR
14th Nov 20192:10 pmRNSHolding(s) in Company
8th Nov 20194:12 pmRNSHolding(s) in Company
4th Nov 20192:16 pmRNSDirector/PDMR shareholding
4th Nov 20197:05 amRNSIssue of equity and notice of general meeting
4th Nov 20197:00 amRNSProposed Acquisition-McCoy Interest & Fundraising
14th Oct 20197:00 amRNSRestructuring of the Paradox project
30th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20197:00 amRNSDirectorate Changes and Board Restructuring
2nd Sep 201910:59 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
22nd Aug 20197:00 amRNSIssue of equity and change to total voting rights
30th Jul 201912:46 pmRNSResult of AGM and update on Board composition
10th Jul 20193:01 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSBoard appointment and update
28th Jun 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSNotice of Annual Results
3rd Jun 20197:00 amRNSTotal Voting Rights
24th May 20197:00 amRNSSubscription completion, board appointment & TVR
20th May 20197:00 amRNSIssue of equity and Board Changes
30th Apr 20197:00 amRNSUpdated Corporate Presentation
23rd Apr 20197:00 amRNSDirectorate Change
12th Apr 20193:40 pmRNSHolding(s) in Company
12th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSIssue of equity and Board Changes
28th Mar 20197:00 amRNSUpdate & Proposed Board Changes
26th Mar 20199:41 amRNSHolding in Company - Correction
12th Mar 20194:17 pmRNSHolding(s) in Company
5th Mar 20196:09 pmRNSHolding(s) in Company
5th Mar 20199:12 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSAcquisition of additional acreage in Paradox Basin
7th Jan 20197:00 amRNSSchlumberger Study Results
6th Dec 20187:00 amRNSOperations Update
27th Nov 20187:00 amRNSDatabase Agreement & North Wash Vanadium update
1st Nov 20187:00 amRNSBLM Approval for Permit to Drill GV 22-1 well
3rd Oct 20187:00 amRNSHolding(s) in Company
25th Sep 20187:00 amRNSHalf-year Report
18th Jul 20181:46 pmRNSHolding(s) in Company
18th Jul 20181:44 pmRNSHolding(s) in Company
3rd Jul 20181:47 pmRNSCantor Fitzgerald initiates research coverage
28th Jun 201811:28 amRNSResult of AGM
28th Jun 20187:00 amRNSInterviews with CEO Matthew Idiens
22nd Jun 20187:00 amRNSCPR - Maiden Contingent Resource and NPV Estimate
19th Jun 20187:00 amRNSAppointment of Financial Adviser and Joint Broker
14th Jun 20187:00 amRNSHolding(s) in Company
6th Jun 20187:00 amRNSFinal Results & notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.